Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Onesource Specialty Pharma: Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2025
News Announcement

Onesource Specialty Pharma: Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2025

23-Jan-2026 Follow Value Research Online on Google download pdfDownload PDF Onesource Specialty Pharma

Outcome of the Board meeting approving the unaudited financial results for the quarter ended December 31 2025

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds